タンパク質工学市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、技術別、エンドユーザー別、地域別、競合別、2020-2030年

タンパク質工学の世界市場は、2024年に28億7,000万米ドルと評価され、2030年には57億4,000万米ドルに達すると予測され、予測期間中のCAGRは12.25%で成長します。

タンパク質工学は、タンパク質の設計、改変、最適化に焦点を当て、新たな機能性を強化または創出するバイオテクノロジーの専門分野です。これらのタンパク質は、触媒作用、シグナル伝達、分子輸送、生体内の構造的完全性において重要な役割を果たしています。分子生物学の技術的進歩により、研究者は現在、特定のタンパク質をコードする遺伝子を合成・改変することができるようになり、新規かつ改良された生物学的分子の開発が容易になりました。抗体治療から農業技術革新に至るまで、人工タンパク質に対する需要が高まるにつれ、市場は急速に拡大し続けています。政府支援の研究資金、民間投資の拡大、AIを活用した薬剤設計などのイノベーション主導の取り組みが、市場開発を加速させています。例えば、Nabla Bio社は2021年に1,100万米ドルを調達し、次世代抗体治療薬のためのAIファースト・プラットフォームを構築しており、この分野の勢いを例証しています。

市場促進要因

技術の進歩

主な市場課題

タンパク質設計の複雑さ

主要市場動向

農業におけるタンパク質工学の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のタンパク質工学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（インスリン、モノクローナル抗体、凝固因子（血液因子＋組織プラスミノーゲン）、ワクチン、成長因子（ホルモン＋サイトカイン）、その他の製品タイプ）
  • 技術別（非合理的タンパク質設計と合理的タンパク質設計）
  • エンドユーザー別（製薬企業、バイオテクノロジー企業、学術機関、調査受託機関（CRO））
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域のタンパク質工学市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のタンパク質工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のタンパク質工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のタンパク質工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのタンパク質工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のタンパク質工学市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• Agilent Technologies Inc.
• Amgen Inc.
• Bruker Corporation
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• Merck KGaA
• Novo Nordisk AS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Protein Engineering Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.74 billion by 2030, growing at a CAGR of 12.25% during the forecast period. Protein engineering is a specialized branch of biotechnology that focuses on designing, modifying, and optimizing proteins to enhance or create new functionalities. These proteins serve vital roles in catalysis, signaling, molecular transport, and structural integrity within living systems. Technological advancements in molecular biology now allow researchers to synthesize and alter genes encoding specific proteins, facilitating the development of novel and improved biological molecules. As the demand grows for engineered proteins in applications ranging from therapeutic antibodies to agricultural innovations, the market continues to expand rapidly. Government-backed research funding, growing private investments, and innovation-driven initiatives-such as AI-enabled drug design-are accelerating market development. For instance, Nabla Bio raised USD 11 million in 2021 to build an AI-first platform for next-generation antibody therapeutics, exemplifying the momentum in this sector.

Key Market Drivers

Technological Advancements

Cutting-edge technologies have been instrumental in driving the evolution and expansion of protein engineering applications across sectors such as healthcare, agriculture, and industrial biotechnology. CRISPR-Cas9 has revolutionized gene editing by enabling precise, efficient protein modifications. Directed evolution techniques allow researchers to mimic natural selection in the laboratory to optimize protein functions through iterative mutation and screening. High-throughput screening (HTS) systems have improved the speed and scale of protein testing, enabling rapid identification of proteins with desirable traits. Computational tools, including AI and molecular modeling, now support accurate protein structure predictions and help streamline the design process. Synthetic biology allows for de novo construction of proteins with tailored functionalities, while advances in protein expression systems (yeast, bacterial, and mammalian) have enhanced recombinant protein yields and quality. Collectively, these innovations are facilitating the development of therapeutic proteins, industrial enzymes, and bioengineered agricultural products with unprecedented efficiency.

Key Market Challenges

Complexity of Protein Design

One of the primary challenges in protein engineering is the inherent complexity of protein design. Proteins rely on intricate three-dimensional folding to function correctly, and even minor alterations in amino acid sequences can result in misfolding and loss of activity. Designing proteins that not only fold properly but also exhibit desired properties-such as stability, specificity, and bioactivity-is a highly complex task. Predicting functional outcomes, ensuring correct protein-ligand or protein-protein interactions, and maintaining stability under physiological conditions remain difficult. Additionally, successful protein design demands multidisciplinary expertise in structural biology, computational modeling, bioinformatics, and chemistry, making collaboration essential. These scientific and technical hurdles limit the pace of development and adoption in certain application areas, especially where precision and reproducibility are critical.

Key Market Trends

Expansion of Protein Engineering in Agriculture

Protein engineering is witnessing a growing footprint in agricultural biotechnology. By modifying plant proteins and enzymes, researchers are enhancing crop traits such as pest resistance, disease tolerance, and resilience to environmental stressors like drought and salinity. Engineered crops can also be enriched with essential nutrients, addressing malnutrition through biofortification. These advances reduce the need for chemical inputs like pesticides and fertilizers, promoting more sustainable and eco-friendly farming practices. Protein engineering enables the development of genetically modified organisms (GMOs) with targeted improvements, supporting food security and environmental sustainability. The trend toward nutrient-dense and climate-resilient crops underscores the increasing role of protein engineering in transforming agriculture globally.

Key Market Players

• Agilent Technologies Inc.
• Amgen Inc.
• Bruker Corporation
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• Merck KGaA
• Novo Nordisk AS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation

Report Scope:

In this report, the Global Protein Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Engineering Market, By Product Type:

• Insulin
• Monoclonal Antibodies
• Coagulation Factors (Blood Factors + Tissue Plasminogen)
• Vaccines
• Growth Factors (Hormones + Cytokine)
• Other Product Types

Protein Engineering Market, By Technology:

• Irrational Protein Design
• Rational Protein Design

Protein Engineering Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Academic Institutions
• Contract Research Organizations (CROs)

Protein Engineering Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Engineering Market.

Available Customizations:

Global Protein Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Insulin, Monoclonal Antibodies, Coagulation Factors (Blood Factors + Tissue Plasminogen), Vaccines, Growth Factors (Hormones + Cytokine), and Other Product Types)
  • 5.2.2. By Technology (Irrational Protein Design and Rational Protein Design)
  • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations (CROs))
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Protein Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Protein Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. India Protein Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Protein Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Protein Engineering Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Technology
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Protein Engineering Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Technology
      • 6.3.5.2.3. By End User

7. Europe Protein Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Protein Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Protein Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Protein Engineering Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Protein Engineering Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. North America Protein Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Protein Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Protein Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Protein Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User

9. South America Protein Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Protein Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Protein Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. Middle East and Africa Protein Engineering Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Engineering Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Protein Engineering Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Protein Engineering Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Protein Engineering Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Agilent Technologies Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Amgen Inc.
• 16.3. Bruker Corporation
• 16.4. Bio-Rad Laboratories Inc.
• 16.5. Eli Lilly and Company
• 16.6. Merck KGaA
• 16.7. Novo Nordisk AS
• 16.8. PerkinElmer Inc.
• 16.9. Thermo Fisher Scientific Inc.
• 16.10.Waters Corporation

17. Strategic Recommendations

18. About Us & Disclaimer